Emerging Biomarkers in Early Disease Detection: A Narrative Review DOI
Rahul Chandran

International Journal of Clinicopathological Correlation, Journal Year: 2024, Volume and Issue: 8(2)

Published: Dec. 27, 2024

The early diagnosis of diseases is a fundamental aspect contemporary medicine, crucial for enhancing patient prognosis and alleviating healthcare system burdens. Biomarkers—measurable indicators biological processes or disease states—have emerged as pivotal tools in diagnostics. This review focuses on novel biomarkers detection cancer, cardiovascular diseases, inflammatory conditions, with special emphasis liquid biopsies, circulating tumor DNA (ctDNA), cardiac troponins, cytokines, exosome-based markers. Furthermore, advancements omics technologies artificial intelligence are highlighted transformative this field. Despite their potential, challenges such validation, standardization, practical integration into clinical workflows persist. Addressing these through collaborative research will ensure play central role diagnostics, ultimately advancing global outcomes.

Language: Английский

Exosomes as Biomarkers and Therapeutic Agents in Neurodegenerative Diseases: Current Insights and Future Directions DOI Creative Commons

Sam Dehghani,

Ozgecan Ocakcı,

Pars Tan Hatipoglu

et al.

Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: March 17, 2025

Abstract Neurodegenerative diseases (NDs) like Alzheimer’s, Parkinson’s, and ALS rank among the most challenging global health issues, marked by substantial obstacles in early diagnosis effective treatment. Current diagnostic techniques frequently demonstrate inadequate sensitivity specificity, whilst conventional treatment strategies encounter challenges related to restricted bioavailability insufficient blood–brain barrier (BBB) permeability. Recently, exosomes—nanoscale vesicles packed with proteins, RNAs, lipids—have emerged as promising agents potential reshape therapeutic approaches these diseases. Unlike drug carriers, they naturally traverse BBB can deliver bioactive molecules affected neural cells. Their molecular cargo influence cell signaling, reduce neuroinflammation, potentially slow neurodegenerative progression. Moreover, exosomes serve non-invasive biomarkers, enabling precise while allowing real-time disease monitoring. Additionally, engineered exosomes, loaded molecules, enhance this capability targeting diseased neurons overcoming barriers. By offering enhanced reduced immunogenicity, an ability bypass physiological limitations, exosome-based present a transformative advantage over existing approaches. This review examines multifaceted role of NDDs, emphasizing their capabilities, intrinsic functions, advanced vehicles.

Language: Английский

Citations

0

Piezoelectric Chemosensors and Biosensors in Medical Diagnostics DOI Creative Commons
Miroslav Pohanka

Biosensors, Journal Year: 2025, Volume and Issue: 15(3), P. 197 - 197

Published: March 20, 2025

This article explores the development and application of innovative piezoelectric sensors in point-of-care diagnostics. It highlights significance bedside tests, such as lateral flow electrochemical providing rapid accurate results directly at patient’s location. paper delves into principles assays, emphasizing their ability to detect disease-related biomarkers through mechanical stress-induced electrical signals. Various applications chemosensors biosensors are discussed, including use detection cancer biomarkers, pathogens, other health-related analytes. also addresses integration materials with advanced sensing technologies improve diagnostic accuracy efficiency, offering a comprehensive overview current advances future directions medical

Language: Английский

Citations

0

The New Frontier of Digital Twins in Next-Gen Wearables for Personalized Health Tracking DOI

A. Ashwini,

G. Santhiya,

S. Balasubramaniam

et al.

Advances in computational intelligence and robotics book series, Journal Year: 2025, Volume and Issue: unknown, P. 107 - 138

Published: March 28, 2025

Next-generation wearable technologies and digital twins are the two ingredients that make field of individual health monitoring innovation. Digital virtual representations people, which assimilate data from devices with biometric use analytic machine learning tools to produce models human change in real-time. The biomechanical equivalents these variables help enhancing examination cyclers' physiological alterations a way creates more compelling proposals for patient-oriented medical treatments. By integrating this twin models, healthcare providers can simulate scenarios, predict potential risks, tailor treatment plans unique needs each patient. As integration continues evolve, it promises unlock new frontiers personalized tracking, revolutionizing individuals clinicians manage wellness.

Language: Английский

Citations

0

Advancing clinical biochemistry: addressing gaps and driving future innovations DOI Creative Commons

Haiou Cao,

Felix Oghenemaro Enwa,

Amaliya Latypova

et al.

Frontiers in Medicine, Journal Year: 2025, Volume and Issue: 12

Published: April 8, 2025

Modern healthcare depends fundamentally on clinical biochemistry for disease diagnosis and therapeutic guidance. The discipline encounters operational constraints, including sampling inefficiencies, precision limitations, expansion difficulties. Recent advancements in established technologies, such as mass spectrometry the development of high-throughput screening point-of-care are revolutionizing industry. biosensor technology wearable monitors facilitate continuous health tracking, Artificial Intelligence (AI)/machine learning (ML) applications enhance analytical capabilities, generating predictive insights individualized treatment protocols. However, concerns regarding algorithmic bias, data privacy, lack transparency decision-making ("black box" models), over-reliance automated systems pose significant challenges that must be addressed responsible AI integration. limitations remain-substantial implementation expenses, system incompatibility issues, information security vulnerabilities intersect with ethical considerations fairness protected information. Addressing these demands coordinated efforts between clinicians, scientists, technical specialists. This review discusses current biochemistry, explicitly addressing reference intervals barriers to implementing innovative biomarkers medical settings. discussion evaluates how advanced technologies multidisciplinary collaboration can overcome constraints while identifying research priorities diagnostic accessibility better delivery.

Language: Английский

Citations

0

Utilizing Technology to Enhance Cancer Education and Support Services DOI
Ushaa Eswaran, Vivek Eswaran, Keerthna Murali

et al.

IGI Global eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 203 - 220

Published: March 7, 2025

This chapter explores how technology is transforming cancer education and support for survivors healthcare providers. It covers innovations like mobile apps, telemedicine, AI, virtual reality, social media, highlighting their impact on sharing information, offering support, delivering care. Through literature reviews, case studies, research, the assesses effectiveness of these tools in improving patient outcomes, enhancing provider education, creating a more connected care community. also addresses challenges digital literacy, accessibility, data privacy, insights professionals, policymakers, tech developers to optimize

Language: Английский

Citations

0

A Gold Nanoparticles and MXene Nanocomposite Based Electrochemical Sensor for Point-of-Care Monitoring of Serum Biomarkers DOI
Yongmei Chen, Xinyu Zhang, Yan Liu

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: April 22, 2025

The development of portable, cost-effective, and highly sensitive biosensors for real-time biomarker detection is crucial advancing point-of-care testing (POCT) wearable health monitoring. Here, we present an integrated portable electrochemical sensor (ip-ECS) that combines gold nanoparticles (AuNPs) MXene-modified screen-printed electrodes (SPEs) with a custom-designed, low-power electronic system monitoring serum biomarkers. AuNPs MXene nanocomposite significantly enhances the performance SPE by providing high density active sites, improved conductivity, catalytic activity. two model molecules (DA UA) validated feasibility ip-ECS, achieving limits as low 1.12 1.11 μM UA DA, respectively. Furthermore, ip-ECS was successfully applied to detect Cys C in human serum, showing linear response range 50-5000 ng/mL strong correlation (ρ = 0.9556) conventional latex immunoturbidimetry (LIA). Clinical validation using samples from pregnant women revealed elevated levels gestational diabetes mellitus (GDM) patients, highlighting sensor's potential early GDM risk prediction. represents significant step forward next-generation POCT, diagnostics, personalized medicine.

Language: Английский

Citations

0

Recent advances in MOF-modified electrochemical sensor for point-of-care detecting cardiac biomarkers DOI
Mohamed Ahmed, Jingyi Bai, Lingxue Kong

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 118277 - 118277

Published: April 1, 2025

Language: Английский

Citations

0

Immune-Related Adverse Events in Immunotherapy: Challenges in Diagnosis, Monitoring, and Management DOI Creative Commons
Mohd Aftab Siddiqui, Afreen Usmani, Mohd Nazam Ansari

et al.

Toxicology Reports, Journal Year: 2025, Volume and Issue: 14, P. 102036 - 102036

Published: April 23, 2025

Language: Английский

Citations

0

Cybersecurity Approaches to IoT Platforms in E-Healthcare Systems DOI

Federick Oscar,

Ugochukwu Okwudili Matthew,

Hope Ayokunle Oladele

et al.

Advances in computational intelligence and robotics book series, Journal Year: 2025, Volume and Issue: unknown, P. 89 - 124

Published: March 7, 2025

This paper explored the crucial areas of cybersecurity in healthcare industry, stressing need to defend infrastructures and private patient information against online attacks. As part their applications electronic (e-healthcare) services for risk management, fraud detection, identity authentication effectively mitigate cyber risks, current proposed bimodal access gateway using artificial neural network (ANN) computer algorithm secure e-healthcare data warehouse infrastructure. In this study, distributed cloud Internet Things (IoT) server systems were created connected through 5G radio frequency enable grid synchronization, resource allocation service-level optimization. approach was adopted strengthen defense keep ahead every evolving threats repositories.

Language: Английский

Citations

0

Development and application of proactive health concepts through artificial intelligence DOI Creative Commons

Anguo Zhao,

Rongkang Li,

Jianquan Hou

et al.

Asian Journal of Surgery, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0